Repository logo

  • Help
  • Log In(current)
    1. Home
    2. NT Health Research
    3. Research and Conference Publications
    4. Radiomics-based outcome prediction in transarterial radioembolization (TARE) of hepatic malignancies: a systematic review and quality appraisal
    Details
    Title

    Radiomics-based outcome prediction in transarterial radioembolization (TARE) of hepatic malignancies: a systematic review and quality appraisal

    Link to article in PubMed
    https://pubmed.ncbi.nlm.nih.gov/42938162/?otool=iaurydwlib
    Author(s)
    Grainger, Richard
    Temperley, Hugo C
    Saadeh, Omar Abu
    O'Sullivan, Niall J
    Mac Curtain, Benjamin M
    Sheahan, Kevin P
    Brennan, Ian
    Ng, Zi Qin
    Mitchell, Tim
    Kelly, Michael E
    Soares, Julian
    Yarmohammadi, Hooman
    Abstract
    Transarterial radioembolization (TARE) with Yttrium-90 (Y) microspheres is an established locoregional treatment for primary and secondary hepatic malignancies. Treatment response is heterogeneous, and accurate pre-procedural prediction of outcome remains a clinical challenge. Radiomics, defined as the high-throughput extraction of quantitative imaging features, may capture subvisual tumour heterogeneity that might be predictive of response, therefore enabling individualised patient selection and treatment planning. To systematically review the current evidence on radiomics-based models derived from pre- and post-procedural imaging for predicting treatment response and survival outcomes in patients with primary and secondary hepatic lesions that were treated with TARE, and to evaluate the methodological quality of included studies. A systematic literature search was conducted across PubMed, Embase, Scopus, and Web of Science. Studies reporting radiomics, texture analysis, dosiomics, or machine learning applied to imaging in patients with hepatic lesions treated with TARE, with at least one reported performance metric, were included. Methodological quality was assessed using the Radiomics Quality Score (RQS) and risk of bias and applicability using the Prediction model Risk Of Bias ASsessment Tool (PROBAST). Due to substantial heterogeneity, a narrative synthesis was performed. Twenty-one studies encompassing 1734 patients were included (up to 73 patients may be counted twice because two cohorts overlap). Studies evaluated patients with hepatocellular carcinoma (HCC; = 12), intrahepatic cholangiocarcinoma (iCC; = 2), colorectal cancer liver metastases (CLMs; = 3), and mixed tumour cohorts ( = 4). Imaging modalities included MRI ( = 9), CT ( = 5), F-FDG PET or PET/CT ( = 3), Y PET or SPECT ( = 2), cone-beam CT ( = 1), and CT perfusion ( = 1). All studies were retrospective, including two post hoc analyses of randomised trial cohorts, and none used external validation. Eighteen studies reported an area under the curve (AUC). The highest reported AUC ranged from 0.71 to 0.90 in eight studies with no validation, from 0.73 to 1.00 in six studies using internal cross-validation, and from 0.80 to 0.90 in four studies using an internal hold-out set. The median RQS was 2 (interquartile range 1 to 5; maximum 36), and all 21 studies had a high overall risk of bias on PROBAST. Radiomic models for predicting TARE outcomes show moderate to high apparent discrimination, but the evidence comes from small retrospective cohorts, is at high risk of bias, and has not been externally validated. Adding clinical variables to radiomic features produced only small gains. Prospective, multi-centre studies with standardised segmentation, harmonised radiomics pipelines, and robust external validation are needed before routine clinical adoption.
    Publication information
    Diagnostics (Basel). 2026 Oct 13;16(20):3322. doi: 10.3390/diagnostics16203322.
    File(s)
    Loading...
    Thumbnail Image
    Download
    Name

    diagnostics-16-03322.pdf

    Description
    Re-used under a Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/
    Size

    1.68 MB

    Format

    Adobe PDF

    Checksum

    (MD5):9472755a2f357a6b45c6b8024c5e5388

    Date Issued
    2026-10-13
    Type
    Journal Article
    Subjects
    SIRT
    TARE
    Y90
    hepatocellular carcinoma
    liver metastases
    machine learning
    radiomics
    survival
    transarterial radioembolization
    treatment response
    Journal Title
    Diagnostics (Basel, Switzerland)
    DOI
    10.3390/diagnostics16203322
    Permanent link to this record
    https://hdl.handle.net/10137/15848
    ISSN
    2075-4418
    Journal Volume Number
    16
    Pages
    3322
    Owning collection
    Research and Conference Publications

    NT Health Library Services acknowledges the Traditional Custodians of Country throughout the Northern Territory and recognises their continuing cultural and spiritual connections to the lands, waters, and communities. We pay our respects to elders past, present and emerging, and extend that respect to all Aboriginal and Torres Strait Islander people across the Northern Territory and beyond, many of whom are represented in our collections.

    © 2025 Northern Territory Government of Australia